SEO Version
www.ebizguides.com
230
Public Services
• Self-service
• ATM
• 1800 Fybeca
• Recipes
Thanks to its distribution system that is considered
to be one of the most efficient in the country and
equipped with the most advanced computerized sys-
tem, drug supply is provided on a daily basis. The
system is aimed at providing the highest quality of
processes and procedures at every step of the distri-
bution and supply chain: from storage and control to
distribution and delivery of drugs to retail outlets, en-
suring that customers always find what they look for.
Driven by the concept of continuous improvement,
the company strives to deliver the best quality of
products and services.
SANOFI AVENTIS
Carlos Haro
General Manager
Av. Shyris N3727 and Naciones Unidad
Edificio Silva Núñez building, 7th floor
Quito, Ecuador
Tel: +593 2 299 4300
Fax: +593 2 299 4348/9
www.sanofiaventis.com.ec
Area of activity: Global Pharmaceutical Company
Employees: 115
Annual turnover: $28 million USD
Always focused on patients’ needs, Sanofi-Aventis
offers a range of essential healthcare assets, includ-
ing a broad-based product portfolio and a worldwide
presence.
The main ambition of Sanofi-Aventis is to become
a diversified global healthcare leader. Its strategy is
built around three priorities to reach its goals and en-
sure sustainable growth:
• Innovation in Research and Development
• Adaptation of Group structures
• External growth opportunities
The global headquarters of the company is located
in Paris, France.
Sanofi-Aventis focuses its activities in 7 therapeutic
areas:
• Cardiovascular
• Thrombosis
• Oncology
• Central Nervous System Diseases
• Metabolic disorders
• Internal Medicine
• Vaccines
The global portfolio of Sanofi-Aventis includes vari-
ous products that are leaders in their respective
areas: thrombosis, cardiovascular disease, sleep
disorders, epilepsy, diabetes and cancer.
In Ecuador, Sanofi-Aventis markets Clexane ®,
Novalgina ®, Deltisona ® B, Lantus ®, Insuman®,
among other products.
The company is distinguished by its high productiv-
ity, innovation and R & D initiatives.
The key factor that contributes to the success and
constant growth of the company in the world is its
productive and innovative R & D organization, with
about 11,000 scientists working in over 20 research
centers on three continents in order to create innova-
tive therapeutics. Currently, there are about thirty R
& D projects undertaken by the company and being
already well developed.
With the scientific support of a regional team of doc-
tors and marketing managers, Sanofi-Aventis in
Ecuador provides efficient and effective therapeutic
responses to diseases in different therapeutic areas.
The company is not only committed to providing the
most effective and reliable medicine to patients, but
also to improving their quality of life.
We are one of the few drug companies that perform
local manufacturing together with our partner Tecno-
andina, the manufacturing arm of Grunenthal.
Carlos Haro
General Manager of Sanofi Aventis
Powered by FlippingBook Publisher